ClearPoint Neuro, Inc. Retained Earnings
ClearPoint Neuro, Inc. (CLPT) had Retained Earnings of -$237.80 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-03
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$237.80M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$226.46M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$216.91M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$209.12M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$237.80M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | -$226.46M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$216.91M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | -$209.12M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$203.23M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$197.40M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$191.37M 10-K · filed 2026-03-17 | |
| 2024-09-30 | -$185.98M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$181.01M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | -$176.60M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | -$172.46M 10-K · filed 2025-02-26 | |
| 2023-09-30 | -$167.84M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$163.03M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | -$155.98M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$150.37M 10-K · filed 2024-03-12 | |
| 2022-09-30 | -$145.98M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | -$142.19M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | -$137.89M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | -$133.93M 10-K · filed 2023-03-01 | |
| 2021-09-30 | -$129.78M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$125.80M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$122.06M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | -$119.52M 10-K · filed 2022-03-09 | |
| 2020-09-30 | -$117.94M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$116.46M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | -$114.79M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | -$112.74M 10-K · filed 2021-03-22 | -$112.74M 10-K · filed 2020-03-27 |
| 2019-09-30 | -$111.09M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | -$109.97M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | -$108.42M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | -$107.20M 10-K · filed 2020-03-27 | |
| 2018-09-30 | -$105.98M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$104.55M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$102.68M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$101.04M 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$98.95M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | -$97.53M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | -$95.52M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$93.87M 10-K · filed 2018-03-21 | |
| 2016-09-30 | -$92.19M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$89.62M 10-Q/A · filed 2016-09-21 | |
| 2016-03-31 | -$87.77M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | -$85.73M 10-K · filed 2017-03-09 | |
| 2015-09-30 | -$84.53M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$84.28M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$81.22M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$77.28M 10-K · filed 2016-03-25 | |
| 2014-09-30 | -$75.36M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$71.72M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$70.12M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | -$72.75M 10-K · filed 2015-03-17 | |
| 2013-09-30 | -$71.04M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | -$67.84M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$66.49M 10-Q/A · filed 2013-08-19 | -$66.45M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$65.67M 10-K · filed 2014-03-28 | -$65.50M 10-K · filed 2013-03-11 |
| 2012-09-30 | -$66.62M 10-K/A · filed 2013-08-19 | -$64.94M 10-Q · filed 2012-11-14 |
| 2012-06-30 | -$63.86M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$63.26M 10-Q/A · filed 2012-06-07 | |
| 2011-12-31 | -$59.79M 10-K/A · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |